{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:48:19Z","timestamp":1760784499302,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10549-018-4853-4","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T10:24:27Z","timestamp":1529317467000},"page":"501-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes"],"prefix":"10.1007","volume":"171","author":[{"given":"Takahiro","family":"Kogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane D.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Harano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sam","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debu","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Litton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-7275","authenticated-orcid":false,"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"issue":"1","key":"4853_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7326\/0003-4819-120-1-199401010-00004","volume":"120","author":"J Bastarrachea","year":"1994","unstructured":"Bastarrachea J, Hortobagyi GN, Smith TL, Kau SWC, Buzdar AU (1994) Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast-cancer. Ann Intern Med 120(1):18\u201325","journal-title":"Ann Intern Med"},{"issue":"7","key":"4853_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1200\/JCO.2005.01.079","volume":"23","author":"CH Kroenke","year":"2005","unstructured":"Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370\u20131378","journal-title":"J Clin Oncol"},{"issue":"5B","key":"4853_CR3","first-page":"2265","volume":"15","author":"A Obermair","year":"1995","unstructured":"Obermair A, Kurz C, Hanzal E, Bancher-Todesca D, Thoma M, Bodisch A, Kubista E, Kyral E, Kaider A, Sevelda P et al (1995) The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res 15(5B):2265\u20132269","journal-title":"Anticancer Res"},{"key":"4853_CR4","doi-asserted-by":"crossref","unstructured":"Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X et al: Beyond axillary lymph node metastasis, BMI and menopausal status are prognostic determinants for triple-negative breast cancer treated by neoadjuvant chemotherapy. Plos One 2015, 10(12)","DOI":"10.1371\/journal.pone.0144359"},{"key":"4853_CR5","doi-asserted-by":"crossref","unstructured":"Jeon YW, Kang SH, Park MH, Lim W, Cho SH, Suh YJ: Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival. BMC Cancer 2015, 15","DOI":"10.1186\/s12885-015-1879-4"},{"key":"4853_CR6","doi-asserted-by":"crossref","unstructured":"Ligibel JA, Cirrincione CT, Liu M, Citron M, Ingle JN, Gradishar W, Martino S, Sikov W, Michaelson R, Mardis E et al: Body mass index, PAM50 subtype, and outcomes in node-positive breast cancer: CALGB 9741 (Alliance). Jnci J Natl Cancer I 2015, 107(9)","DOI":"10.1093\/jnci\/djv179"},{"issue":"1","key":"4853_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1200\/JCO.1999.17.1.120","volume":"17","author":"PJ Goodwin","year":"1999","unstructured":"Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, Trudeau M, Hood N, Redwood S (1999) Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17(1):120\u2013129","journal-title":"J Clin Oncol"},{"issue":"4","key":"4853_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1467-789X.2010.00805.x","volume":"12","author":"V Vance","year":"2011","unstructured":"Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12(4):282\u2013294","journal-title":"Obes Rev"},{"issue":"3","key":"4853_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1023\/B:BREA.0000014037.48744.fa","volume":"83","author":"MN Harvie","year":"2004","unstructured":"Harvie MN, Campbell IT, Baildam A, Howell A (2004) Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 83(3):201\u2013210","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4853_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1200\/JCO.2005.04.036","volume":"23","author":"ML Irwin","year":"2005","unstructured":"Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R (2005) Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 23(4):774\u2013782","journal-title":"J Clin Oncol"},{"issue":"9","key":"4853_CR11","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1200\/JCO.2001.19.9.2381","volume":"19","author":"W Demark-Wahnefried","year":"2001","unstructured":"Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer BK (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19(9):2381\u20132389","journal-title":"J Clin Oncol"},{"issue":"1","key":"4853_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01886732","volume":"7","author":"RT Chlebowski","year":"1986","unstructured":"Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR (1986) Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7(1):23\u201330","journal-title":"Breast Cancer Res Treat"},{"key":"4853_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/1471-2407-10-648","volume":"10","author":"E Thivat","year":"2010","unstructured":"Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, Gadea E, Planchat E, Kwiatkowski F, Mouret-Reynier MA, Chollet P et al (2010) Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10:648","journal-title":"BMC Cancer"},{"issue":"25","key":"4853_CR14","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1200\/JCO.2007.14.4527","volume":"26","author":"JK Litton","year":"2008","unstructured":"Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26(25):4072\u20134077","journal-title":"J Clin Oncol"},{"issue":"9938","key":"4853_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384(9938):164\u2013172","journal-title":"Lancet"},{"issue":"2","key":"4853_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.0.CO;2-W","volume":"89","author":"RM Elledge","year":"2000","unstructured":"Elledge RM, Green S, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, Martino S, Osborne CK (2000) Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study. Int J Cancer 89(2):111\u2013117","journal-title":"Int J Cancer"},{"issue":"4","key":"4853_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.7150\/jca.10580","volume":"6","author":"T Kogawa","year":"2015","unstructured":"Kogawa T, Fouad TM, Wei C, Masuda H, Kai K, Fujii T, El-Zein R, Chavez-MacGregor M, Litton JK, Brewster A et al (2015) Association of body mass index changes during neoadjuvant chemotherapy with pathologic complete response and clinical outcomes in patients with locally advanced breast cancer. J Cancer 6(4):310\u2013318","journal-title":"J Cancer"},{"issue":"5","key":"4853_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1158\/1055-9965.EPI-08-1094","volume":"18","author":"HB Nichols","year":"2009","unstructured":"Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC et al (2009) Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomark Prev 18(5):1403\u20131409","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"4853_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-009-0512-0","volume":"119","author":"E de Azambuja","year":"2010","unstructured":"de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JPA, Vicente M, Giuliani R, Nordenskjold B, Gutierez J, Andersson M et al (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02\u201398 trial. Breast Cancer Res Treat 119(1):145\u2013153","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4853-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:08:25Z","timestamp":1589720905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4853"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4853-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"11 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Debu Tripathy has received research grants from Novartis and consultant\/advisory role from Novartis and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A waiver of informed consent was authorized by institutional review board because the study was a retrospective chart review involving no diagnostic or therapeutic intervention.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}